- GlobeNewswire•last month
-Adds Two Rare Disease Medicines and Further Diversifies Company Revenue-. -Raises Full-Year 2016 Net Sales Guidance and Confirms Full-Year 2016 Adjusted EBITDA Guidance-. DUBLIN, Ireland, Oct. 25, 2016-- ...
- GlobeNewswire•2 months agoGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Raptor Pharmaceutical Corp. (RPTP)
NEW YORK, Oct. 06, 2016-- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Raptor Pharmaceutical Corp. in the United States District Court for the District of Delaware ...
- Investor's Business Daily•2 months ago
The buzz around biotechs amped up a notch in the past week as Kite Pharma (KITE) and G.W. Pharmaceuticals (GWPH) socked away double-digit gains. Kite soared 10% in massive trade on Tuesday after announcing its KTE-C19 treatment showed a 47% complete remission rate in patients with the most common form of Non-Hodgkin lymphoma. The stock quickly backed off to end...
RPTP : Summary for Raptor Pharmaceutical Corp. - Yahoo Finance
Raptor Pharmaceuticals Corp. (RPTP)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||8.95 - 9.05|
|52 Week Range||2.94 - 9.05|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-8.70|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|